SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron.
Viruses
; 14(1)2022 01 02.
Article
in En
| MEDLINE
| ID: mdl-35062283
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
COVID-19 Vaccines
/
SARS-CoV-2
Limits:
Humans
Language:
En
Journal:
Viruses
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Suiza